Information
5 Digital-ro 26-gil, Guro District, Seoul, South Korea
+82 2-6220-7721
-
-
Overview
- Summary
- NanoEntek is a leading company in the point-of-care diagnostics field, specializing in Bio-MEMS core technology, which fuses Micro-Electro-Mechanical-Systems (MEMS) with biotechnology, for the research, development, production, and sale of life science laboratory equipment, in-vitro diagnostic devices, and related consumables and solutionsNanoEntek is a leading company in the point-of-care diagnostics field, specializing in Bio-MEMS core technology, which fuses Micro-Electro-Mechanical-Systems (MEMS) with biotechnology, for the research, development, production, and sale of life science laboratory equipment, in-vitro diagnostic devices, and related consumables and solutions
- Key Products/Technologies
- FREND™ System: A rapid quantitative immunofluorescence in-vitro diagnostic device utilizing fluorescent microfluidics technology, providing quantitative test results with micro-samples within 3 minutes, with several FDA 510(k) cleared assays, Model F10FREND™ System: A rapid quantitative immunofluorescence in-vitro diagnostic device utilizing fluorescent microfluidics technology, providing quantitative test results with micro-samples within 3 minutes, with several FDA 510(k) cleared assays, Model F10
- ADAM™ MC2: An automated fluorescence cell counter equipped with advanced optical and CMOS technology, enabling accurate cell counting and viability measurement using AO or PI fluorescence staining methods in under 25 seconds, utilized for cell therapy quality control (QC)ADAM™ MC2: An automated fluorescence cell counter equipped with advanced optical and CMOS technology, enabling accurate cell counting and viability measurement using AO or PI fluorescence staining methods in under 25 seconds, utilized for cell therapy quality control (QC)
- EVE™ HT FL: A high-throughput fluorescence cell counter, capable of efficiently analyzing large numbers of samplesEVE™ HT FL: A high-throughput fluorescence cell counter, capable of efficiently analyzing large numbers of samples
- ADAM™ rWBC HT: A residual white blood cell counter, designated as a standard instrument for blood quality control (QC) by the American Red CrossADAM™ rWBC HT: A residual white blood cell counter, designated as a standard instrument for blood quality control (QC) by the American Red Cross
- ADAM™ II-CD34: A fluorescence hematopoietic stem cell counter, supporting precise counting and analysis of specific cell typesADAM™ II-CD34: A fluorescence hematopoietic stem cell counter, supporting precise counting and analysis of specific cell types
- EVE™ HT A26: A cell mass analysis automation robot, an all-in-one platform for automated cell pretreatment, counting, and analysis, based on a 7-axis robot system, processing 96 samples within 15 minutesEVE™ HT A26: A cell mass analysis automation robot, an all-in-one platform for automated cell pretreatment, counting, and analysis, based on a 7-axis robot system, processing 96 samples within 15 minutes
- Lab-on-a-Chip Platform Technology: A core technology combining MEMS and Micro-Fluidics to implement biological analysis processes on a tiny chip the size of a fingernailLab-on-a-Chip Platform Technology: A core technology combining MEMS and Micro-Fluidics to implement biological analysis processes on a tiny chip the size of a fingernail
- NT-IT-BT (Nano-Information-Bio) Convergence Technology: The capability to organically combine nano, information, and bio technologies to create innovative bio-solutionsNT-IT-BT (Nano-Information-Bio) Convergence Technology: The capability to organically combine nano, information, and bio technologies to create innovative bio-solutions
- Core Advantages
- Bio-MEMS and Lab-on-a-Chip Core Technology: Possession of unique Lab-on-a-Chip platform technology integrating micro-electro-mechanical systems with biotechnologyBio-MEMS and Lab-on-a-Chip Core Technology: Possession of unique Lab-on-a-Chip platform technology integrating micro-electro-mechanical systems with biotechnology
- Rapid and Accurate Point-of-Care Diagnostic Capability: Provision of fast and precise diagnostic and analysis results with minimal samples, based on microfluidics technologyRapid and Accurate Point-of-Care Diagnostic Capability: Provision of fast and precise diagnostic and analysis results with minimal samples, based on microfluidics technology
- Global Market Recognition of Technology: Multiple FDA 510(k) cleared products and designation as a standard instrument by the American Red CrossGlobal Market Recognition of Technology: Multiple FDA 510(k) cleared products and designation as a standard instrument by the American Red Cross
- Extensive Intellectual Property Portfolio: Over 100 domestic and international patents filed and registered related to NT-IT-BT convergence technologyExtensive Intellectual Property Portfolio: Over 100 domestic and international patents filed and registered related to NT-IT-BT convergence technology
- Integrated Business Operation Model: A consistent system encompassing research and development, production, and sales of life science laboratory equipment and in-vitro diagnostic devicesIntegrated Business Operation Model: A consistent system encompassing research and development, production, and sales of life science laboratory equipment and in-vitro diagnostic devices
- Leadership in Next-Generation Bio-Robot Technology: Development of automated cell mass analysis robots and ongoing discussions for supply with global pharmaceutical companies for market expansionLeadership in Next-Generation Bio-Robot Technology: Development of automated cell mass analysis robots and ongoing discussions for supply with global pharmaceutical companies for market expansion
- Target Industries
- Life Science Research: Support for various bioengineering experiments such as cell counting, cell viability measurement, and cell analysisLife Science Research: Support for various bioengineering experiments such as cell counting, cell viability measurement, and cell analysis
- Medical In-Vitro Diagnostics: Clinical diagnosis, prognosis determination, and health status assessment through point-of-care testing (POCT) devicesMedical In-Vitro Diagnostics: Clinical diagnosis, prognosis determination, and health status assessment through point-of-care testing (POCT) devices
- Cell Therapy Development and Quality Control: Precise cell counting and quality control during the research and production processes of cell therapies, including stem cells and CAR-T cellsCell Therapy Development and Quality Control: Precise cell counting and quality control during the research and production processes of cell therapies, including stem cells and CAR-T cells
- Pharmaceutical and Biotechnology Industry: Provision of cell analysis and diagnostic solutions in drug discovery and biopharmaceutical manufacturing processesPharmaceutical and Biotechnology Industry: Provision of cell analysis and diagnostic solutions in drug discovery and biopharmaceutical manufacturing processes
- Blood Quality Control: Quality management of blood products, including residual white blood cell counting in blood preparationsBlood Quality Control: Quality management of blood products, including residual white blood cell counting in blood preparations
- Skin Diagnostics: Diagnosis of biomarkers in skin cells and assessment of aging through collaboration with global beauty companiesSkin Diagnostics: Diagnosis of biomarkers in skin cells and assessment of aging through collaboration with global beauty companies
- Major Markets
- South Korea, ChinaSouth Korea, China
- GermanyGermany
- United StatesUnited States
- Certifications/Patents
- Over 100 domestic and international patents filed and registered related to NT-IT-BT convergence technologyOver 100 domestic and international patents filed and registered related to NT-IT-BT convergence technology
- Patents held for core Lab-on-a-Chip platform technologyPatents held for core Lab-on-a-Chip platform technology
- Patent for 'Microparticle Counting Device' (core technology for automated cell counters)Patent for 'Microparticle Counting Device' (core technology for automated cell counters)
- Japanese patent registration for 'Fluid Analysis Chip' (technology applied to FREND kits)Japanese patent registration for 'Fluid Analysis Chip' (technology applied to FREND kits)
- US patent registration for 'Sample Pre-treatment System and Control Method' (for FREND system)US patent registration for 'Sample Pre-treatment System and Control Method' (for FREND system)
- US FDA 510(k) clearance for 9 items of FREND™ System, including PSA Plus, TSH, Free T4, Testosterone, and Vitamin DUS FDA 510(k) clearance for 9 items of FREND™ System, including PSA Plus, TSH, Free T4, Testosterone, and Vitamin D
- Designation of ADAM-rWBC as a standard instrument for blood quality control (QC) by the American Red CrossDesignation of ADAM-rWBC as a standard instrument for blood quality control (QC) by the American Red Cross
- US FDA Emergency Use Authorization for COVID-19 diagnostic kit 'FREND COVID-19 total Ab'US FDA Emergency Use Authorization for COVID-19 diagnostic kit 'FREND COVID-19 total Ab'
- German Federal Ministry of Health approval for COVID-19 diagnostic kit 'FREND COVID19 Ag'German Federal Ministry of Health approval for COVID-19 diagnostic kit 'FREND COVID19 Ag'
Introduction
Location
5 Digital-ro 26-gil, Guro District, Seoul, South Korea
클릭하여 위치 살펴보기
